Thymitis and myasthenia gravis
No abstract listed.
Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic alpha-bungarotoxin receptors
Three-year observation of a myasthenic syndrome concurrent with other autoimmune syndromes in a patient with thymoma
Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis
Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin
Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus
Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen
Calcium-dependent effect of the thymic polypeptide thymopoietin on the desensitization of the nicotinic acetylcholine receptor
Electrophysiological changes similar to those of myasthenia gravis in rats with experimental autoimmune thymitis
Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptides
Systemic lupus erythematosus triggered by adult thymectomy in myasthenia gravis patient: report of a case
Comparative efficacy of various routes of administration of thymopentin (TP-5) with consideration of degradative mechanisms
Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.